BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Marrone L, Marchi PM, Azzouz M. Circumventing the packaging limit of AAV-mediated gene replacement therapy for neurological disorders. Expert Opin Biol Ther 2021. [PMID: 34904932 DOI: 10.1080/14712598.2022.2012148] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Fare CM, Rhine K, Lam A, Myong S, Shorter J. Molecular determinants of Karyopherin-β2 chaperone and disaggregation activity.. [DOI: 10.1101/2022.09.14.508025] [Reference Citation Analysis]
2 Maturana CJ, Chan A, Verpeut JL, Engel EA. The Alphaherpesvirus Latency Associated Promoter 2 (LAP2) Drives Strong Transgene Expression in Peripheral Tissue Depending on Administration Route and AAV Serotype.. [DOI: 10.1101/2022.08.04.502832] [Reference Citation Analysis]
3 Maturana CJ, Verpeut JL, Engel EA. Single-Cell Quantification of Triple-AAV Vector Genomes Coexpressed in Neurons. Curr Protoc 2022;2:e430. [PMID: 35616444 DOI: 10.1002/cpz1.430] [Reference Citation Analysis]